Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 7/20 | 0.42 |
| ▸ | ITGAV | P06756 | 6/20 | 0.42 |
| ▸ | SUCNR1 | Q9BXA5 | 4/20 | 0.35 |
| ▸ | BCHE | P06276 | 2/20 | 0.34 |
| ▸ | CNR2 | P34972 | 2/20 | 0.34 |
| ▸ | THRA | P10827 | 4/20 | 0.33 |
| ▸ | THRB | P10828 | 4/20 | 0.33 |
| ▸ | PPARG | P37231 | 3/20 | 0.33 |
| ▸ | RXRA | P19793 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21101051 | 0.96 | ITGB3 (0.46) | ITGB3ITGAVSUCNR1BCHECNR2 | |
| SCHEMBL21100867 | 0.95 | ITGB3 (0.46) | ITGB3ITGAVSUCNR1BCHECNR2 | |
| SCHEMBL21100869 | 0.90 | ITGB3 (0.46) | ITGB3ITGAVSUCNR1BCHECNR2 | |
| SCHEMBL23709968 | 0.89 | ITGB3 (0.47) | ITGB3ITGAVSUCNR1BCHECNR2 | |
| SCHEMBL21479478 | 0.87 | ITGB3 (0.45) | ITGB3ITGAVSUCNR1BCHECNR2 | |
| SCHEMBL21475357 | 0.87 | ITGB3 (0.46) | ITGB3ITGAVSUCNR1BCHECNR2 | |
| SCHEMBL27446341 | 0.84 | ITGB3 (0.36) | ITGB3ITGAVSUCNR1THRATHRB | |
| SCHEMBL21100765 | 0.83 | ITGB3 (0.60) | ITGB3ITGAV | |
| SCHEMBL27446214 | 0.82 | ITGB3 (0.38) | ITGB3ITGAVSUCNR1THRATHRB | |
| SCHEMBL21475355 | 0.79 | ITGB3 (0.60) | ITGB3ITGAV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11077082-B2 | Composition and method for dual targeting in treatment of neuroendocrine tumors | NANOPHARMACEUTICALS, LLC (US) | 2021-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11077082-B2 | Composition and method for dual targeting in treatment of neuroendocrine tumors | THRB, TSHR, SLC6A2 | ITGB3 12/4885ITGAV 14/4885SUCNR1 1342/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.